New life in a sleeper: thalidomide and Crohn's disease.
Sands
B E
BE
Podolsky
D K
DK
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D013723:Teratogens; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide